Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re-evaluation, given the increasingly dominant B.1.617.2 (Delta) variant. In this study, we investigated the effectiveness of these vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Pouwels, Koen B., Pritchard, Emma, Matthews, Philippa C., Stoesser, Nicole, Eyre, David W., Vihta, Karina-Doris, House, Thomas, Hay, Jodie, Bell, John I., Newton, John N., Farrar, Jeremy, Crook, Derrick, Cook, Duncan, Rourke, Emma, Studley, Ruth, Peto, Tim E. A., Diamond, Ian, Walker, A. Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674129/
https://www.ncbi.nlm.nih.gov/pubmed/34650248
http://dx.doi.org/10.1038/s41591-021-01548-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674129/
https://www.ncbi.nlm.nih.gov/pubmed/34650248
http://dx.doi.org/10.1038/s41591-021-01548-7

Ejemplares similares